Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-04-17

Clinical Trial Update: Micra AV Tracking During Exercise Testing [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Micra AV tracking during exercise testing has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micra AV (pacemaker)

Snippet

Sponsor: Duke University | Conditions: Heart Block AV | Phase 4 | Status: WITHDRAWN